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We report the total synthesis of a series of pyrrolizidine ana-
logues of casuarine (1) and their 6-O-α-glucoside derivatives.
The synthetic strategy is based on a totally regio- and stereo-
selective 1,3-dipolar cycloaddition of suitably substituted
alkenes and a carbohydrate-based nitrone. We also report
the evaluation of the biological activity of casuarine and its
derivatives towards a wide range of glycosidases and a mo-
Introduction
Iminosugars are very attractive carbohydrate mimics in
which the endocyclic oxygen atom is replaced by the more
basic, trivalent nitrogen atom.[1] In their protonated form,
iminosugars resemble the transition state or intermediate
generated during the hydrolysis reaction catalysed by glyco-
sidases, key hydrolytic enzymes involved in many physiolog-
ical functions. Since the discovery of the inhibitory proper-
ties of iminoalditols towards glycosidases, they have re-
ceived increasing attention as diagnostic compounds as well
as tools for the investigation of the structures, functions and
catalytic mechanisms of carbohydrate-processing en-
zymes.[2,3] Furthermore, given the important role of glyco-
sidases and glycosyltransferases in controlling the structures
and functions of carbohydrates at the cell surface, competi-
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lecular modeling study focused on glucoamylase (GA) in
which the binding modes of the newly synthesized com-
pounds within the enzyme cavity are investigated. The re-
sults highlight the prominent structural features of casuarine
and its derivatives that make them selective glucoamylase
inhibitors.
tive inhibitors of these classes of enzymes are potential anti-
diabetes, anti-viral and anti-cancer agents.[1,2] Recently,
interesting immunosuppressive activities have been discov-
ered for this class of compounds.[4] In the past 40 years,
more than 100 polyhydroxylated alkaloids have been iso-
lated from plants and microorganisms[5] with structures that
include polyhydroxylated piperidines, pyrrolidines, indolizi-
dines, pyrrolizidines and nortropanes. For instance, the pi-
peridine alkaloid 1-deoxynojirimycin (DNJ, Scheme 1), pre-
pared first by Paulsen et al. in 1967[6a] and then isolated
from a species of Moris (Moraceae),[6b] was found to
strongly inhibit α-glucosidases.[5a] N-Alkylated derivatives
of DNJ have found applications as anti-diabetic drugs (i.e.,
Miglitol, Glyset) or anti-HIV agents (Glycovir, SC
49483).[2a] The indolizidine alkaloid (+)-lentiginosine
(Scheme 1) was isolated in 1990 from the leaves of Astraga-
lus lentiginosus and was found to inhibit amyloglucosid-
ases.[7] Its non-natural enantiomer (–)-lentiginosine was re-
cently discovered to possess proapoptotic activity towards
tumoral cells.[8] Castanospermine (Scheme 1), isolated in
1981 from the seeds, leaves and barks of Castanospermum
australe and in 1988 from the seeds, leaves and barks of
Alexa sp.,[5a] and its ester and salt derivatives are able to
inhibit tumour growth and metastasis.[9]
Casuarine (1, Scheme 2) and its 6-O-α-glucoside, casuar-
ine-6-O-α-glucopyranoside (2, Scheme 2), have been iso-
lated from the bark of Casuarina equisetifolia L. (Casua-
rinaceae) and from the leaves of Eugenia jambolana Lam.
(Myrtaceae).[10] We recently reported that casuarine (1) is
able to inhibit a human maltase-glucoamylase (MGAM,
